Latest News and Press Releases

Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "The Global Quantum Technology Market 2026-2046: Computing, Sensors, Communications & Software" report has been added to ResearchAndMarkets.com's...

Dublin, May 12, 2026 (GLOBE NEWSWIRE) -- The "The Global Quantum Computing Supply Chain 2026-2036: Materials, Components and Enabling Hardware" report has been added to ResearchAndMarkets.com's...

Resume: Periodens resultat før skat blev et overskud på 2,3 mio. kr. og efter skat et overskud på 1,8 mio. kr., mod et underskud på 0,2 mio. kr. før skat og et underskud på 0,1 mio. kr. efter skat...

Dantax A/S nedjusterer forventningerne til regnskabsåret 2025/2026. Selskabet forventer nu et resultat før finansielle poster i niveauet -1,0 – 0,0 mio. kr. mod tidligere udmeldte forventninger på...

U.S. Food and Drug Administration (FDA) review of oxylanthanum carbonate (OLC) New Drug Application (NDA) resubmission remains on track, with a Prescription Drug User Fee Act (PDUFA) target action...

CARMEL, Ind., May 12, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic...

SEATTLE and VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve and the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused...

– First-ever FDA approved PROTAC supports the further development and potential of Arvinas’ pipeline – – Announced FDA Approval of VEPPANU™ (vepdegestrant) for the treatment of ESR1m, ER+/HER2-...

CorVel to host May 20, 2026 earnings webcast covering financial results, strategy, outlook, and Q&A with CEO Michael Combs and CFO Brian Nichols.

Initiated enrollment of Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera (PV) and myelofibrosis (MF) The Company expects to file the IND for...